An Analysis of GlaxoSmithKline

11293 Words23 Pages

An Analysis of GlaxoSmithKline The business that I have done research into is GlaxoSmithKline. This company is a globalised research-based pharmaceutical public limited company. Its ownership structure has changed a great deal since the original company was first established in 1715. Originally a pharmacy, the company has expanded, merged with and taken over other companies over the decades. The last of these was the merger between Glaxo Wellcome and SmithKline Beecham, which formed the current company of GlaxoSmithKline. GlaxoSmithKline’s business is to discover effective medicines and healthcare products for people throughout the world and create shareholder value. They are one of the world’s leading producers of prescription medicines, vaccines and consumer healthcare products (Toiletries, Drinks). These products include SEROXAT/PAXIL, AUGMENTIN, WELLBUTRIN and ZOTRAN, all of which are pharmaceutical products. AQUAFRESH, LUCOZADE, NIQUITIN CQ and SENSODYNE, these are known as consumer healthcare products. HEPATITUS and INFANRIX, which are vaccines. The company provides over 7% of the total global pharmaceutical sales and supply 24% of the world’s vaccines. They manufacture and distribute more than 10 million packs of medicine every day. GlaxoSmithKline now has a Board of 13 Directors, and a further 15 members of The Corporate Executive Team. These members are the Presidents of the various global and national departments. Below I have set out a table to show the Advantages and Disadvantages of a public limited company. ADVANTAGES DISADVANTAGES Shares offered for sale on the stock exchange, so that large amounts of capital can be generated. Shareholders protected by limited liabilit... ... middle of paper ... ...ibit the already efficient practices from continuing. This would therefore have a knock-on effect to reduce the overall production sites and effectiveness of the other parts of the company. The practices already in place help the Group to achieve its objectives by; Continually reviewing its source of supply-This meets the objective of focus on performance, supply and cost Continually applying quality management-This meets the objectives of absolute attention to compliance and team work and talent expression Continually benchmarking other companies- This meets the objective of focusing on their own performances to meet the aim of being a world leader. Continually reviewing its practices through out the Operational Excellence program- This meets the objective of streamlining the processes used within the GMS Bibliography 1) WWW.GSK.CO.UK

Open Document